EXACIS BIOTHERAPEUTICS
Startup
EXACIS BIOTHERAPEUTICS
Description
Exacis Biotherapeutics develops allogeneic NK and T cells designed for treatment of solid tumors and hematogenous malignancies.
Resources
EXACIS BIOTHERAPEUTICS
Address
United States
Contact
info@exacis.com
Description
Exacis Biotherapeutics develops allogeneic NK and T cells designed for treatment of solid tumors and hematogenous malignancies.
Resources
Matchmaking
Connect with EXACIS BIOTHERAPEUTICS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways